Neteera Secures ~$13M Series B Funding for Contactless Patient Monitoring

Rhea-AI Summary

Neteera Technologies Ltd., an Israeli startup focused on patient monitoring, has successfully closed a $13M Series B funding round led by Aescuvest with participation from Omega Healthcare Investors (NYSE: OHI) and other investors. The funds will enhance sales and production of Neteera's contactless patient monitoring solutions. This technology allows for continuous monitoring of patients' vital signs without the need for contact, improving patient care and reducing caregiver workload. In conjunction with the funding, Neteera and Omega have established a strategic partnership aimed at integrating this technology within Omega's skilled nursing facilities across the US. The partnership follows positive feedback from pilot deployments, highlighting its potential to improve care and reduce hospitalizations.

Positive

• Successful closure of a $13M Series B funding round.
• Strategic partnership established between Neteera and Omega Healthcare Investors to enhance patient monitoring.
• Neteera's contactless technology shows promise in reducing hospitalizations and improving patient care.

Negative

• None.

Funding round led by Aescuvest alongside Omega Healthcare Investors

JERUSALEM, April 25, 2023 /PRNewswire/ -- Neteera Technologies Ltd., an Israeli-based startup disrupting the patient monitoring market, today announced the successful closing of a ~$13M Series B funding round. The round was led by Aescuvest, a prominent healthcare investment firm combined with existing and new investors, including Omega Healthcare Investors - a leading US-based Healthcare REIT (NYSE: OHI) with a particular focus on skilled nursing facility and assisted living facility operators across the United States and the United Kingdom, Nanz Family Office, Ankor Holding and Esas Private Equity. In addition, Neteera and Omega entered into a strategic partnership to offer Neteera's technology to Omega's healthcare operating partners.

With this latest funding round, Neteera will accelerate sales, production and deployment of its contactless patient monitoring solution and further feature development for its proprietary medical sensing platform. The technology is designed to enable continuous monitoring of patients' bio markers without the need for contact or patient involvement, streamlining patient monitoring, improving outcomes, and reducing the burden on clinical staff.

"Aescuvest is committed to funding healthcare developments that have a positive impact on society, and we believe that Neteera's innovative technology has the potential to revolutionize the way we monitor and care for patients," said Sebastian Gührs, Partner & Head of Investment at Aescuvest.

Omega Healthcare Investors joined the investment round as well and cemented a strategic partnership with Neteera. As part of the relationship, Neteera will become Omega's strategic partner for contactless patient monitoring and will offer its remote patient monitoring platform to Omega's network of long-term care and skilled nursing facilities across the US.

"We are excited to partner with Neteera," said Matthew Gourmand, Senior Vice President, Corporate Strategy of Omega Healthcare Investors. "We deployed their technology across a test group of facilities and received positive feedback from the operators, highlighting a reduction in hospitalizations and early recognition of changes in resident clinical needs. We believe this technology has the capacity to help caregivers, as they seek to provide high levels of care and comfort for their residents."

Founded in 2015, Neteera quickly gained recognition for its unique FDA-cleared contactless remote patient monitoring platform. The platform, capable of continuous and seamless monitoring of patients' bio markers in real-time, is improving patient care and operator efficiencies all over the globe. Together with the FDA clearance and the latest funding round, the company is poised to further disrupt the healthcare industry and bring its technology to more patients in need.

"We are thrilled to partner with Aescuvest and Omega as we continue to develop and scale our game changing solution," said Neteera CEO, Isaac Litman. "With this funding and with Omega's strategic partnership, we will be able to expand our reach and accelerate our mission to improve patient outcomes while reducing the burden on clinical staff."

About Aescuvest:

Aescuvest is a healthcare investment company that focuses on funding digital healthcare ventures to make a significant impact. As the operator of a dedicated investment platform, the company offers exclusive access to promising healthcare ventures and facilitates direct investments through SPV structures. By providing entrepreneurial investments in a thriving market, Aescuvest enables investors to participate in lucrative healthcare investment opportunities.

About Omega Healthcare Investors:

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.

About Neteera:

Neteera's FDA-cleared continuous, contactless, passive vital signs and bio-data monitoring solution provides better patient monitoring both for the crisis ridden healthcare system and home health. Our sensing platform eliminates the need for device manipulation, removal of clothing, and caregiver presence. Neteera's technology is a based on a safe, maintenance-free, sub-THZ micro-radar on chip sensor solution that protects privacy as it is not based on a camera. We improve care and ultimately reduce healthcare costs by enabling optimal comfort for patients.

Contact:
Sebastian Gührs
Head of Investment
Aescuvest
+491744333221
sebastian.guehrs@aescuvest.eu

Logo - https://mma.prnewswire.com/media/2058115/Aescuvest_Logo.jpg
Logo - https://mma.prnewswire.com/media/2058116/Omega_Healthcare_Investors_Logo.jpg
Logo - https://mma.prnewswire.com/media/2058117/Neteera_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/neteera-secures-13m-series-b-funding-for-contactless-patient-monitoring-301802870.html

SOURCE Aescuvest

FAQ

What was the amount raised in Neteera's Series B funding round?

Neteera raised $13M in its Series B funding round.

Who led the funding round for Neteera Technologies?

The funding round was led by Aescuvest.

How will the funding impact Neteera's operations?

The funding will accelerate sales, production, and deployment of Neteera's patient monitoring technology.

What is the strategic partnership between Neteera and Omega Healthcare Investors?

Neteera will offer its contactless patient monitoring technology to Omega's network of healthcare facilities.

What benefits does Neteera's technology provide according to the press release?

The technology enables continuous monitoring of vital signs, improves patient outcomes, and reduces the burden on clinical staff.